We are on a mission to radically improve treatment decisions and outcomes in cancer care through fast, precise and affordable solutions for diagnosis, prognosis and stratification of cancer patients. Our vision is that every person with cancer gets the right treatment at the right time. This would improve the lives of millions of people around the world, while substantially reducing the global costs of healthcare. We leverage artificial intelligence combined with very large population representative data sets and associated clinical outcome data, to provide decision support tools and second read solutions to pathology labs and oncology clinics, as well helping pharma and biotech companies identify patients who benefit from novel therapies.